Expression of Interest for C-CAMP Netherlands Global Innovation Catapult
By Centre for Cellular and Molecular Platforms (C-CAMP)
Check your eligibility
Sign up and we'll tell you whether your startup qualifies for this grant.
Quick Answer
C-CAMP, in partnership with the Netherlands Embassy and Invest in Holland, offers Indian health tech companies a catapult program to enter and expand in the Dutch health ecosystem.
Results & next round
Applications for this round closed on 5 July 2026. The organiser has not published a selection list that we can verify yet.
Selections for this programme are announced by Centre for Cellular and Molecular Platforms (C-CAMP). Official links are listed under Sources below.
We update this page when results are published, and when the next round opens.
About this grant
This program is designed to bridge the gap between innovative Indian health tech startups and the thriving Dutch healthcare ecosystem. C-CAMP, in collaboration with the Netherlands Embassy in India and Invest in Holland, has launched the Global Innovation Catapult to serve as a critical entry and expansion pathway for promising Indian companies. The initiative targets health technologies that can significantly benefit Dutch healthcare professionals and patients by addressing key needs such as reducing employee workload, enhancing operational efficiency, expanding care into non-hospital settings like homecare, promoting patient self-sufficiency, and optimizing tasks through automation to limit human intervention. Through this unique catapult program, C-CAMP and its partners aim to foster strategic international collaborations, enable market validation for Indian innovations, and facilitate significant market expansion for selected companies within the Netherlands and the broader European Union. This program is a testament to the commitment of both India and the Netherlands to drive global healthcare innovation through cross-border partnerships, offering a unique opportunity for Indian innovators to gain a foothold in a highly developed European market.
Eligibility
See if you're eligible
Full eligibility criteria — entity type, stage, sector, founder profile and registration requirements — plus your fit for this program. Sign up to view.
Grant providers
The Centre for Cellular and Molecular Platforms, or C-CAMP, is a Bengaluru life sciences hub conceptualised by the Department of Biotechnology, Government of India, in 2009. It sits on the NCBS-TIFR campus in Bengaluru as part of the Bangalore Life Sciences Cluster (BLiSC),…
Learn moreBenefits & Funding
- Fund type
- Grant
- Equity
- Equity-free
- Repayment
- Non-repayable
What You Get
While this program does not offer direct cash grants or equity investments, it provides invaluable market access and comprehensive soft-landing support for Indian health tech innovators looking to enter the European market via the Netherlands. Selected companies will receive expert knowledge and regulatory guidance specific to the Dutch healthcare landscape, including insights into market dynamics, regulatory pathways, and best practices. Furthermore, they will benefit from a round table service provided by the Dutch Ministry of Health, Welfare and Sport (VWS) through HI-NL, offering early insights into market entry strategies and stakeholder needs. Crucially, the program facilitates direct meetings and networking opportunities with key stakeholders in the Dutch healthcare sector, organized by the Netherlands Foreign Investment Agency (NFIA). This structured support is designed to validate innovations, establish strategic partnerships, and enable successful market expansion into the Netherlands and the EU.
- Cohort size
- 5 startups
- Bootstrap friendly
- Yes
Timelines & Process
Selection Process
The selection process for the C-CAMP Netherlands Global Innovation Catapult is a rigorous, multi-stage evaluation designed to identify Indian health tech companies with the highest potential for impact and successful integration into the Dutch healthcare ecosystem. Initially, applications submitted via the Expression of Interest (EOI) form will undergo a thorough screening by C-CAMP and its partners, evaluating factors such as technological innovation, alignment with focus areas, commercial maturity (scaling up, revenue-generating, or piloting phase), and regulatory preparedness, with a strong preference for CE certification or a clear pathway to it. A shortlist of promising companies will then be invited for in-person meetings and interactions. During these sessions, a selection committee comprising experts from C-CAMP, the Health Team of the Netherlands Embassy, the Netherlands Foreign Investment Agency (NFIA), and other Dutch healthcare stakeholders will conduct in-depth assessments. The committee will evaluate the company's innovation, its value proposition for the Dutch market, and the team's capacity for international expansion. The final decision will select five companies based on their strategic fit, growth potential, and ability to address critical needs within the Dutch healthcare sector, preparing them for the facilitated market-access visit.
Application Process
- 1
Open Call Launched
C-CAMP officially opens the Expression of Interest for applications.
Provider - 2
- 3
- 4
- 5
- 6
How to apply
Four steps from draft to disbursement — one action each.
- 1
Draft your application
Answer the form inside the grant tracker — AI drafts each response using your past answers, so you're not starting from a blank page.
- 2
See the questions before you start
Download every question this programme's application form asks, so you can prepare your answers offline before opening the portal.
- 3
Line up your documents
Keep every document from the checklist ready in one folder. Missing docs are the #1 reason applications get bounced.
- 4
Submit on the official portal
Use the official application link and verify all details before final submission.
- 5
Follow up
Reach out 5–7 days after submitting to confirm receipt and ask about the review timeline.
Frequently Asked Questions
What kind of funding does this program provide?
The C-CAMP Netherlands Global Innovation Catapult is a market-access and soft-landing program, not a funding program. It does not provide any cash grants, investments, or repayable loans. Its value lies in facilitating market entry, providing regulatory guidance, and offering networking opportunities in the Dutch healthcare ecosystem.
Who is eligible to apply for this program?
Indian health tech companies that have reached a commercial stage (scaling up, revenue generating, or in active deployment/piloting phase) are eligible. Priority is given to technologies that reduce employee workload, enhance operational efficiency, expand care to non-hospital settings, promote patient self-sufficiency, or optimize tasks through automation. Companies with CE certification or a clear pathway to it will receive priority.
What are the key benefits for selected companies?
Selected companies will gain access to expert knowledge and regulatory support for the Dutch healthcare market, participate in a round table service with the Dutch Ministry of Health, Welfare and Sport (VWS), and receive facilitated introductions to key stakeholders in the Dutch healthcare sector by the Netherlands Foreign Investment Agency (NFIA). The program aims to enable partnerships, market validation, and expansion into the Netherlands and the broader EU.
Are travel and accommodation expenses covered?
No, participants are responsible for bearing their own travel and accommodation costs for the visit to the Netherlands. The program focuses on providing market access, knowledge, and networking support.
What is the deadline for applications?
The call for applications closes on July 5th, 2026. Interested companies should submit their Expression of Interest before this date.
What types of health technologies are in focus?
The program seeks technologies that reduce employee workload (e.g., automated vitals, AI diagnostics), enhance operational efficiency (e.g., smart wards, AI assistants), expand care to non-hospital settings (e.g., wearable biosensors, remote monitoring), promote patient self-sufficiency (e.g., portable heart monitoring, at-home rehab), and optimize tasks through automation (e.g., neonatal therapy, medicine dispensaries).
Sources
Data on this page is compiled from official program and provider references.
